Literature DB >> 2124955

Modulation of lymphocyte proliferation by enzymes that degrade amino acids.

J C Chuang1, C L Yu, S R Wang.   

Abstract

In a previous study we demonstrated thirteen amino acids to be essential and two to be partially essential for lymphocyte proliferation. Arginine is one of the essential amino acids, and the highly purified arginase strongly inhibited lymphocyte proliferation. The modulation of lymphocyte growth by various amino acid-degrading enzymes was studied. Peripheral lymphocytes were cultured in RPMI 1640 with or without amino acid-degrading enzyme for 72 h. A total of 17 commercial L-amino acid-degrading enzymes were studied. At 10 micrograms/ml, both lysine decarboxylase and asparaginase completely inhibited lymphocyte proliferation, arginase resulted in 78% inhibition and tyrosinase 57% inhibition. Other enzymes inhibited less than 20% lymphocyte proliferation; they included alanine dehydrogenase, arginine decarboxylase, aspartase, glutamic decarboxylase, glutamic dehydrogenase, glutaminase, histidase, histidine decarboxylase, leucine dehydrogenase, phenylalanine decarboxylase, phenylalanine hydroxylase, tryptophanase, and tyrosine decarboxylase. All four enzymes that strongly inhibited lymphocyte proliferation degraded amino acids that are essential for lymphocyte growth.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2124955      PMCID: PMC1535509          DOI: 10.1111/j.1365-2249.1990.tb05473.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Amino acid metabolism in mammalian cell cultures.

Authors:  H EAGLE
Journal:  Science       Date:  1959-08-21       Impact factor: 47.728

2.  L-asparaginase and blastogenesis.

Authors:  G Astaldi; G R Burgio; J Krc; R Genova; A A Astaldi
Journal:  Lancet       Date:  1969-02-22       Impact factor: 79.321

3.  Reversal by L-glutamine of the inhibition of lymphocyte mitosis caused by E. coli asparaginase.

Authors:  M S Simberkoff; L Thomas
Journal:  Proc Soc Exp Biol Med       Date:  1970-02

4.  The inhibition of lymphocyte blastogenesis by L-asparaginase.

Authors:  R Ohno; E M Hersh
Journal:  Blood       Date:  1970-02       Impact factor: 22.113

5.  Antineoplastic activity of highly purified bacterial glutaminases.

Authors:  J Roberts; J S Holcenberg; W C Dolowy
Journal:  Nature       Date:  1970-09-12       Impact factor: 49.962

6.  Asparagine synthetase in asparaginase resistant and susceptible mouse lymphomas.

Authors:  M D Prager; N Bachynsky
Journal:  Biochem Biophys Res Commun       Date:  1968-04-05       Impact factor: 3.575

7.  Comparison of the immunosuppressive effects of asparaginases from Escherichia coli and Vibrio succinogenes.

Authors:  D L Durden; J A Distasio
Journal:  Cancer Res       Date:  1980-04       Impact factor: 12.701

8.  Modulation of lymphocyte proliferation by murine liver extract.

Authors:  H L Su; M H Huang; C L Yu; S H Han; B N Chiang; S R Wang
Journal:  Asian Pac J Allergy Immunol       Date:  1987-06       Impact factor: 2.310

9.  Modulation of human lymphocyte proliferation by amino acids.

Authors:  J C Chuang; C L Yu; S R Wang
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

10.  Asparagine synthetase activity of mouse leukemias.

Authors:  B Horowitz; B K Madras; A Meister; L J Old; E A Boyes; E Stockert
Journal:  Science       Date:  1968-05-03       Impact factor: 47.728

View more
  8 in total

1.  Purification of a multipotent antideath activity from bovine liver and its identification as arginase: nitric oxide-independent inhibition of neuronal apoptosis.

Authors:  F Esch; K I Lin; A Hills; K Zaman; J M Baraban; S Chatterjee; L Rubin; D E Ash; R R Ratan
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

Review 2.  Metabolomics in childhood diabetes.

Authors:  Brigitte I Frohnert; Marian J Rewers
Journal:  Pediatr Diabetes       Date:  2015-09-30       Impact factor: 4.866

Review 3.  Metabolomic Biomarkers in the Progression to Type 1 Diabetes.

Authors:  Anne Julie Overgaard; Simranjeet Kaur; Flemming Pociot
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

4.  Integrative Genomics of Emphysema-Associated Genes Reveals Potential Disease Biomarkers.

Authors:  Ma'en Obeidat; Yunlong Nie; Nick Fishbane; Xuan Li; Yohan Bossé; Philippe Joubert; David C Nickle; Ke Hao; Dirkje S Postma; Wim Timens; Marc A Sze; Casey P Shannon; Zsuzsanna Hollander; Raymond T Ng; Bruce McManus; Bruce E Miller; Stephen Rennard; Avrum Spira; Tillie-Louise Hackett; Wan Lam; Stephen Lam; Rosa Faner; Alvar Agusti; James C Hogg; Don D Sin; Peter D Paré
Journal:  Am J Respir Cell Mol Biol       Date:  2017-10       Impact factor: 6.914

5.  Immune-related edemagenic activity of glutamines and glutamic acid, components of immunomodulatory agents.

Authors:  Z Zídek
Journal:  Agents Actions       Date:  1994-10

Review 6.  Branched-chain amino acids in liver diseases.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

7.  Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes.

Authors:  Maren Pflueger; Tuulikki Seppänen-Laakso; Tapani Suortti; Tuulia Hyötyläinen; Peter Achenbach; Ezio Bonifacio; Matej Orešič; Anette-G Ziegler
Journal:  Diabetes       Date:  2011-11       Impact factor: 9.461

Review 8.  Myeloid Cell-Derived Arginase in Cancer Immune Response.

Authors:  Tomasz M Grzywa; Anna Sosnowska; Paweł Matryba; Zuzanna Rydzynska; Marcin Jasinski; Dominika Nowis; Jakub Golab
Journal:  Front Immunol       Date:  2020-05-15       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.